Targeting AMPK for cardiac protection: opportunities and challenges.
about
The Role of Endoplasmic Reticulum Stress and Unfolded Protein Response in AtherosclerosisAMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatmentPast strategies and future directions for identifying AMP-activated protein kinase (AMPK) modulatorsMitochondria as a therapeutic target in heart failureNeuronal nitric oxide synthase in hypertension - an updateAMP activated protein kinase is indispensable for myocardial adaptation to caloric restriction in mice.AMPK protects proximal tubular cells from stress-induced apoptosis by an ATP-independent mechanism: potential role of Akt activation.17-β estradiol attenuates ovariectomy-induced changes in cardiomyocyte contractile function via activation of AMP-activated protein kinase.AMP-activated protein kinase β-subunit requires internal motion for optimal carbohydrate bindingDeficiency in AMPK attenuates ethanol-induced cardiac contractile dysfunction through inhibition of autophagosome formation.Maternal nutrient restriction predisposes ventricular remodeling in adult sheep offspring.Enhancement of Glucose Metabolism via PGC-1α Participates in the Cardioprotection of Chronic Intermittent Hypobaric Hypoxia.A novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation.Localisation of AMPK γ subunits in cardiac and skeletal musclesA High Throughput Assay for Discovery of Small Molecules that Bind AMP-activated Protein Kinase (AMPK).β-subunit myristoylation functions as an energy sensor by modulating the dynamics of AMP-activated Protein Kinase.Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy.Role of endoplasmic reticulum stress in atherosclerosis and diabetic macrovascular complications.The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review.The AMPK Activator Aicar Ameliorates Age-Dependent Myocardial Injury in Murine Hemorrhagic Shock.Comprehensive Characterization of AMP-Activated Protein Kinase Catalytic Domain by Top-Down Mass SpectrometryKnockdown of AMPKα2 Promotes Pulmonary Arterial Smooth Muscle Cells Proliferation via mTOR/Skp2/p27(Kip1) Signaling Pathway.AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney.Metformin Exerts Beneficial Effects in Hemorrhagic Shock in an Ampkα1-Independent Manner.Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway.Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.Donor pretreatment with adenosine monophosphate-activated protein kinase activator protects cardiac grafts from cold ischaemia/reperfusion injury.Effects of neonatal dexamethasone administration on cardiac recovery ability under ischemia-reperfusion in 24-wk-old rats.
P2860
Q26769783-F7372C1E-FBF4-4186-8772-E037044A1AF4Q26827415-EF3BB87D-8E15-433F-A2BD-C7C807E667B6Q26864679-1D442683-6675-4EA4-B5E5-7A8591F74DFAQ27005632-5580E330-9309-4868-92A9-E0683B5435D8Q28077204-C84EA07D-46C4-4062-9C86-B39181018D63Q34635436-0AA62884-76D5-4602-8BE6-B83F71B4B313Q35601626-4154ABE4-6E70-492F-858E-9E7926F9303DQ35602858-2C3D39F0-4033-4119-986A-E7B72CDB9636Q35694226-B331D4F7-B5D4-467F-BD99-72BB5AADD64DQ35965054-94EC1FB3-7BA3-4AE6-91B2-059B26720DEDQ36788075-D8F8AACD-5D13-4ACD-B29B-923FBCED2DCEQ36978797-BF13484B-ECCC-4A9C-BD07-EC2AD300296FQ37014884-3E046D2B-3E9D-4F0B-A81D-51A3CB16CD9DQ37368921-663B16EF-82B9-4FB8-B743-0DD745891CF5Q37372078-3CB5E982-197E-442B-AD2B-80B898EE1109Q37522391-C3C8FB3D-EDB6-4313-98F7-207250078420Q38010782-7316E758-A65B-443A-8D70-7A0259D37C84Q38233882-895C69FE-D0AC-4312-A561-AB1CF1E98728Q38875916-4FBD4DE4-83A5-48DF-ACD7-03D19ABE80BFQ39500637-49875E46-527E-445D-AC92-A3B1AA8DCE33Q40406207-9F903D87-74A1-483F-8618-2596D0AF84DCQ41974999-8B524AD6-453A-4386-A821-8204E69127B6Q41989991-1B667784-3CA9-4800-9B9E-6CC57603B4BEQ47796176-440054FF-4C91-4A59-A606-9A8EC60FC39CQ48215167-D230B9A1-B129-4BFB-B2A7-BA781255E9DFQ51125944-B1E81500-2FC4-461E-847F-4506D0A33E7AQ53511596-970803BC-6057-4828-AE13-EF95E4E89C10Q54231822-15865CA5-0FBD-42DF-B0C4-06C470EBE2D8Q55026578-ACB23C43-0307-4809-BB01-A01C2992106A
P2860
Targeting AMPK for cardiac protection: opportunities and challenges.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting AMPK for cardiac protection: opportunities and challenges.
@en
Targeting AMPK for cardiac protection: opportunities and challenges.
@nl
type
label
Targeting AMPK for cardiac protection: opportunities and challenges.
@en
Targeting AMPK for cardiac protection: opportunities and challenges.
@nl
prefLabel
Targeting AMPK for cardiac protection: opportunities and challenges.
@en
Targeting AMPK for cardiac protection: opportunities and challenges.
@nl
P2860
P1476
Targeting AMPK for cardiac protection: opportunities and challenges.
@en
P2860
P304
P356
10.1016/J.YJMCC.2010.12.004
P577
2010-12-13T00:00:00Z